Beauty

Silab unveils Metallomia for iron imbalance in menopausal skin

The French ingredient maker says its patented detoxifying active restarts ferritinophagy and targets metallo-aging linked to iron dysregulation.

Naomi SekiguchiNovember 12, 20265 min read17 views
A translucent serum droplet, marshmallow-root forms and an abstract skin-barrier cross-section appear in a soft laboratory-inspired still life.

French cosmetics ingredient manufacturer Silab has introduced Metallomia, a detoxifying active ingredient developed for menopausal skin. The launch focuses on what Silab describes as a deficiency in ferritinophagy, a process that controls iron release to meet cellular needs.

According to Silab, modeling work on menopausal skin showed that reduced ferritinophagy leads to a lack of bioavailable iron, which in turn promotes premature skin aging. The company calls this phenomenon metallo-aging. UV exposure can worsen it, Silab says, because UV favors degradation of iron/ferritin complexes, causing massive and uncontrolled iron release and significant oxidative stress. The distinction matters because iron is essential for cells but can become damaging when released without control.

Mechanism and reported effects

Metallomia is designed to relaunch ferritinophagy in menopausal skin. Silab says the ingredient facilitates iron provision and relaunches key epidermal functions. By reducing iron/ferritin complexes, it is also intended to limit oxidative stress when skin is exposed to UV.

Silab reports that this targeted mechanism significantly reduces metallo-aging. In Caucasian volunteers, skin was described as revitalized after 14 days, with a reinforced skin barrier and a more unified, radiant complexion. In Asian volunteers, pigment spots were significantly reduced after 28 days, according to the company. When Caucasian volunteers applied the ingredient before UV exposure, Silab says it prevented lipid peroxidation and limited the appearance of redness within hours after exposure. Silab presents these outcomes as visible effects on skin quality and tone.

The reported results are company claims. The supplied announcement does not give volunteer numbers, full study protocols or the endpoint methods used for barrier, complexion, spot and redness measurements, so the findings should be read in that context.

Sourcing and formulation

For Metallomia, Silab examined the molecular composition of marshmallow roots, which are particularly rich in mucilages. The company established a traced supply chain with French partners. It says the supply has been validated against criteria in the European Pharmacopoeia and authenticated by DNA barcoding. To benefit from the root’s mucilage richness, Silab developed a specific enzyme engineering process to extract polyuronides.

Metallomia is patented and recommended for all care products intended for menopausal skin at a dose of 0.5% to 2%. It is available in aqueous solution and is described as easy to formulate. Silab says it complies with biodiversity regulations, has a natural origin content of 100% under ISO 16128, and meets international cosmetics regulations in markets including Europe, the USA, China and Japan.

Silab is positioning Metallomia for topical products aimed at menopausal skin. The ingredient’s water-soluble form, documented botanical supply and compliance with international cosmetics regulations are presented as support for formulators working in this category. The recommended use level is 0.5% to 2%.